Jesus Osada

Prof. Dr. Jesus Osada

University of Zaragoza, Spain
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
José J. GaforioJosé J. Gaforio
José J. Gaforio
Francesco VisioliFrancesco Visioli
Francesco Visioli
CDCatalina Alarcòn de-la-Lastra
Catalina Alarcòn de-la-Lastra
OCOlga Castañer
Olga Castañer
Miguel Delgado-RodríguezMiguel Delgado-Rodríguez
Miguel Delgado-Rodríguez
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
The Mediterranean diet is considered as the foremost dietary regimen and its adoption is associated with the prevention of degenerative diseases and an extended longevity. The preeminent features of the Mediterranean diet have been agreed upon and the consumption of olive oil stands out as the most peculiar one. Indeed, the use of olive oil as the nearly exclusive dietary fat is what mostly characterizes the Mediterranean area. Plenty of epidemiological studies have correlated that the consumption of olive oil was associated with better overall health. Indeed, extra virgin olive oil contains (poly)phenolic compounds that are being actively investigated for their purported biological and pharma-nutritional properties. On 18 and 19 May 2018, several experts convened in Jaen (Spain) to discuss the most recent research on the benefits of olive oil and its components. We reported a summary of that meeting (reviewing several topics related to olive oil, not limited to health) and concluded that substantial evidence is accruing to support the widespread opinion that extra virgin olive oil should, indeed, be the fat of choice when it comes to human health and sustainable agronomy.

19 July 2018 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
JLJosé M. Lou‐Bonafonte
José M. Lou‐Bonafonte
RBRoberto Martínez Beamonte
Roberto Martínez Beamonte
TSTeresa Sanclemente
Teresa Sanclemente
JSJoaquín C. Surra
Joaquín C. Surra
LHLuis V. Herrera‐Marcos
Luis V. Herrera‐Marcos
Jesus OsadaJesus Osada
Jesus Osada

18 August 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Rosa GarrigaRosa Garriga
Rosa Garriga
THTania Herrero-Continente
Tania Herrero-Continente
MPMiguel Palos
Miguel Palos
Vicente Luis CebollaVicente Luis Cebolla
Vicente Luis Cebolla
Jesus OsadaJesus Osada
Jesus Osada
María Rodríguez-YoldiMaría Rodríguez-Yoldi
María Rodríguez-Yoldi
Carbon nanomaterials have attracted increasing attention in biomedicine recently to be used as drug nanocarriers suitable for medical treatments, due to their large surface area, high cellular internalization and preferential tumor accumulation, that enable these nanomaterials to transport chemotherapeutic agents preferentially to tumor sites, thereby reducing drug toxic side effects. However, there are widespread concerns on the inherent cytotoxicity of carbon nanomaterials, which remains controversial to this day, with studies demonstrating conflicting results. We investigated here in vitro toxicity of various carbon nanomaterials in human epithelial colorectal adenocarcinoma (Caco-2) cells and human breast adenocarcinoma (MCF-7) cells. Carbon nanohorns (CNH), carbon nanotubes (CNT), carbon nanoplatelets (CNP), graphene oxide (GO), reduced graphene oxide (GO) and nanodiamonds (ND) were systematically compared, using Pluronic F-127 dispersant. Cell viability after carbon nanomaterial treatment followed the order CNP < CNH < RGO < CNT < GO < ND, being the effect more pronounced on the more rapidly dividing Caco-2 cells. CNP produced remarkably high reactive oxygen species (ROS) levels. Furthermore, the potential of these materials as nanocarriers in the field of drug delivery of doxorubicin and camptothecin anticancer drugs was also compared. In all cases the carbon nanomaterial/drug complexes resulted in improved anticancer activity compared to that of the free drug, being the efficiency largely dependent of the carbon nanomaterial hydrophobicity and surface chemistry. These fundamental studies are of paramount importance as screening and risk-to-benefit assessment towards the development of smart carbon nanomaterial-based nanocarriers.

1 May 2009 in Physiological Genomics
Verified
Journal Article
Open access
PDF file
NGNatalia Guillén
Natalia Guillén
MNMaría A. Navarro
María A. Navarro
CACarmen Arnal
Carmen Arnal
ENEnda Noone
Enda Noone
José Miguel Arbones-MainarJosé Miguel Arbones-Mainar
José Miguel Arbones-Mainar
Jesus OsadaJesus Osada
Jesus Osada
Trans-10, cis-12-conjugated linoleic acid (CLA)-enriched diets promote fatty liver in mice, while cis-9, trans-11-CLA ameliorates this effect, suggesting regulation of multiple genes. To test this hypothesis, apoE-deficient mice were fed a Western-type diet enriched with linoleic acid isomers, and their hepatic gene expression was analyzed with DNA microarrays. To provide an initial screening of candidate genes, only 12 with remarkably modified expression between both CLA isomers were considered and confirmed by quantitative RT-PCR. Additionally mRNA expression of 15 genes involved in lipid metabolism was also studied. Ten genes (Fsp27, Aqp4, Cd36, Ly6d, Scd1, Hsd3b5, Syt1, Cyp7b1, and Tff3) showed significant associations among their expressions and the degree of hepatic steatosis. Their involvement was also analyzed in other models of steatosis. In hyperhomocysteinemic mice lacking Cbs gene, only Fsp27, Cd36, Scd1, Syt1, and Hsd3b5 hepatic expressions were associated with steatosis. In apoE-deficient mice consuming olive-enriched diet displaying reduction of the fatty liver, only Fsp27 and Syt1 expressions were found associated. Using this strategy, we have shown that expression of these genes is highly associated with hepatic steatosis in a genetic disease such as Cbs deficiency and in two common situations such as Western diets containing CLA isomers or a Mediterranean-type diet. Conclusion: The results highlight new processes involved in lipid handling in liver and will help to understand the complex human pathology providing new proteins and new strategies to cope with hepatic steatosis.

4 July 2012 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
PDF file
JLJosé M. Lou‐Bonafonte
José M. Lou‐Bonafonte
CACarmen Arnal
Carmen Arnal
MNMaría A. Navarro
María A. Navarro
Jesus OsadaJesus Osada
Jesus Osada
As olive oil is the main source of calories in the Mediterranean diet, a great deal of research has been devoted to characterizing its role in atherosclerosis. Virgin olive oil is an oily matrix that contains hydrocarbons, mainly squalene; triterpenes such as uvaol, erythrodiol, oleanolic, and maslinic acid; phytosterols; and a wide range of phenolic compounds comprising simple phenols, flavonoids, secoiridoids, and lignans. In this review, we analyze the studies dealing with atherosclerosis and olive oil in several species. A protective role of virgin olive oil against atherosclerosis has been shown in ApoE‐deficient mice and hamsters. In the former animal, sex, dose, and dietary cholesterol are modulators of the outcome. Contradictory findings have been reported for rabbits, a circumstance that could be due to the profusion of experimental designs, differing in terms of doses and animal strains, as well as sources of olive oils. This role has yet to be fully validated in humans. Minor components of olive oil have been shown to be involved in atherosclerosis protection. Nevertheless, evidence of the potential of isolated compounds or the right combination of them to achieve the antiatherosclerotic effect of virgin olive oil is inconclusive and will undoubtedly require further experimental support.

Verified
Journal Article
Open access
PDF file
EHElena Horna-Terrón
Elena Horna-Terrón
APAlberto Pradilla
Alberto Pradilla
Cristina Sanchez De DiegoCristina Sanchez De Diego
Cristina Sanchez De Diego
Jesus OsadaJesus Osada
Jesus Osada
Thioredoxin domain-containing 5 (TXNDC5) is a member of the protein disulfide isomerase family, acting as a chaperone of endoplasmic reticulum under not fully characterized conditions As a result, TXNDC5 interacts with many cell proteins, contributing to their proper folding and correct formation of disulfide bonds through its thioredoxin domains. Moreover, it can also work as an electron transfer reaction, recovering the functional isoform of other protein disulfide isomerases, replacing reduced glutathione in its role. Finally, it also acts as a cellular adapter, interacting with the N-terminal domain of adiponectin receptor. As can be inferred from all these functions, TXNDC5 plays an important role in cell physiology; therefore, dysregulation of its expression is associated with oxidative stress, cell ageing and a large range of pathologies such as arthritis, cancer, diabetes, neurodegenerative diseases, vitiligo and virus infections. Its implication in all these important diseases has made TXNDC5 a susceptible biomarker or even a potential pharmacological target.